Status:
RECRUITING
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical ...
Detailed Description
The Institute of Medicine recommends that each cancer patient receive a survivorship care plan that summarizes information important to the individual's long-term care, including the following: (1) ca...
Eligibility Criteria
Inclusion
- Patients must be 18 years or older at the time of consent
- Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend).
- Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months.
- English-speaking
Exclusion
- Patient will be excluded if they have had recurrence of their colorectal cancer.
- Patient's with severe cognitive impairment
- Patient's with schizophrenia or other psychosis
- Patients currently in hospice care
Key Trial Info
Start Date :
September 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05346796
Start Date
September 9 2022
End Date
May 31 2027
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University School of Medicine
Indianapolis, Indiana, United States, 46202